Amarin (AMRN) Issues Encouraging Update on Vascepa MARINE, ANCHOR Phase 3s
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Amarin (AMRN) Vascepa Added to CVS (CVS) Health Plan
April 8, 2013 11:34 AM EDTAmarin (Nasdaq: AMRN) is ticking higher Monday following news that retail pharmaceutical giant CVS (NYSE: CVS) added Vascepa (icosapent ethyl) to its High Deductible Health Plan (HDHP) - Health Savings Account (HSA) Preventative Therapy Drug List. Vascepa... More
